Group One Trading’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$134K Sell
1,014
-316
-24% -$41.9K ﹤0.01% 4463
2025
Q4
$189K Buy
+1,330
New +$193K ﹤0.01% 4424
2024
Q3
Sell
-3,951
Closed -$542K 7099
2024
Q2
$544K Buy
+3,951
New +$542K ﹤0.01% 2484
2023
Q2
Sell
-12,470
Closed -$1.22M 8009
2023
Q1
$1.26M Buy
+12,470
New +$1.3M ﹤0.01% 1937
2022
Q3
Sell
-2,780
Closed -$282K 7990
2022
Q2
$271K Sell
2,780
-48,709
-95% -$4.5M ﹤0.01% 4002
2022
Q1
$4.83M Buy
+51,489
New +$4.36M ﹤0.01% 1577
2021
Q1
Sell
-222
Closed -$23.3K 7865
2020
Q4
$21K Buy
+222
New +$21.4K ﹤0.01% 5499
2020
Q3
Sell
-7,201
Closed -$833K 6382
2020
Q2
$879K Buy
7,201
+5,809
+417% +$642K ﹤0.01% 2149
2020
Q1
$120K Sell
1,392
-5,744
-80% -$562K ﹤0.01% 3153
2019
Q4
$767K Sell
7,136
-1,219
-15% -$128K 0.01% 2103
2019
Q3
$753K Buy
8,355
+3,419
+69% +$319K 0.01% 1994
2019
Q2
$417K Buy
4,936
+2,080
+73% +$171K ﹤0.01% 2297
2019
Q1
$252K Buy
2,856
+2,591
+978% +$217K ﹤0.01% 2533
2018
Q4
$19K Sell
265
-10,895
-98% -$1.04M ﹤0.01% 4042
2018
Q3
$1.37M Buy
+11,160
New +$1.27M 0.01% 1444
2018
Q1
Sell
-16,092
Closed -$1.36M 5142
2017
Q4
$1.25M Sell
16,092
-2,352
-13% -$160K 0.01% 1540
2017
Q3
$1.13M Buy
18,444
+17,912
+3,367% +$945K 0.01% 1463
2017
Q2
$24K Buy
+532
New +$25.8K ﹤0.01% 3870
2016
Q2
Sell
-17,559
Closed -$808K 4825
2016
Q1
$694K Buy
+17,559
New +$697K 0.01% 1455
2015
Q4
Sell
-24,355
Closed -$1.24M 4956
2015
Q3
$969K Buy
24,355
+16,209
+199% +$783K 0.01% 1268
2015
Q2
$389K Buy
8,146
+5,426
+199% +$230K 0.01% 1998
2015
Q1
$108K Buy
+2,720
New +$97.3K ﹤0.01% 2853
2014
Q4
Sell
-37,503
Closed -$711K 5135
2014
Q3
$588K Buy
+37,503
New +$561K 0.01% 1503
2014
Q1
Sell
-11,908
Closed -$204K 5442
2013
Q4
$111K Sell
11,908
-15,462
-56% -$151K ﹤0.01% 2942
2013
Q3
$310K Buy
27,370
+21,672
+380% +$298K 0.01% 2011
2013
Q2
$76K Buy
+5,698
New +$70K ﹤0.01% 3066

Other funds holding NBIX